Previous close | 99.62 |
Open | 98.91 |
Bid | 99.83 x 100 |
Ask | 101.27 x 100 |
Day's range | 98.91 - 101.82 |
52-week range | 82.86 - 178.64 |
Volume | |
Avg. volume | 45,222 |
Market cap | 543.397M |
Beta (5Y monthly) | 0.82 |
PE ratio (TTM) | 592.59 |
EPS (TTM) | 0.17 |
Earnings date | 24 May 2024 |
Forward dividend & yield | 0.64 (0.64%) |
Ex-dividend date | 31 May 2024 |
1y target est | 130.00 |
Mesa Laboratories, Inc. ( NASDAQ:MLAB ) shareholders should be happy to see the share price up 12% in the last quarter...
Lakewood, Colo., April 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the closing of its Amended and Restated Credit Agreement (the “Credit Agreement”), which provides up to $200 million of senior secured debt through a syndicate of banks led by JPMORGAN CHASE BANK, N.A. The Credit Agreement includes a $75 million senior secured term loan facility (the “Term Loan”) and a $125 million senior secured revolving credit facili
SM and MLAB made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 8, 2023.